Income Statement

v3.19.1
Statements of Loss - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]      
Research and development expenses, net $ 459,184 $ 720,527 $ 317,907
General and administrative expenses 919,694 617,087 410,982
Operating loss (1,378,878) (1,337,614) (728,889)
Financing income (expenses), net 921,337 (1,337,758) 75,428
Net loss $ (457,541) $ (2,675,372) $ (653,461)
Basic and diluted net loss per share $ (0.006) $ (0.04) $ (0.01)
Basic and diluted weighted average number of ordinary shares outstanding 70,869,924 68,587,261 62,467,556

Source